Olivier Nègre

4.5k total citations
24 papers, 596 citations indexed

About

Olivier Nègre is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Olivier Nègre has authored 24 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Hematology. Recurrent topics in Olivier Nègre's work include Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Olivier Nègre is often cited by papers focused on Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). Olivier Nègre collaborates with scholars based in France, United States and Thailand. Olivier Nègre's co-authors include Emmanuel Payen, D Fradelizi, Philippe Leboulch, Yves Beuzard, David J. Rawlings, Christopher T. Lux, Andrew M. Scharenberg, Sowmya Pattabhi, Pierre‐Jacques Ferret and Suparerk Borwornpinyo and has published in prestigious journals such as Blood, Biochemical Journal and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Olivier Nègre

24 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Nègre France 13 429 232 198 91 84 24 596
A‐M Faussat France 6 236 0.6× 90 0.4× 94 0.5× 101 1.1× 46 0.5× 6 416
Kanit Bhukhai Thailand 9 183 0.4× 54 0.2× 74 0.4× 24 0.3× 47 0.6× 25 306
Raveen Basran Canada 12 197 0.5× 164 0.7× 116 0.6× 99 1.1× 73 0.9× 19 398
Yuanxin Ye China 12 265 0.6× 98 0.4× 30 0.2× 20 0.2× 59 0.7× 43 417
F E Cash United States 12 468 1.1× 99 0.4× 274 1.4× 61 0.7× 189 2.3× 12 683
Surinder Safaya United States 12 208 0.5× 73 0.3× 316 1.6× 92 1.0× 260 3.1× 22 539
Ariadna González‐del Angel Mexico 13 182 0.4× 169 0.7× 39 0.2× 84 0.9× 8 0.1× 65 420
A. Eigel Germany 12 193 0.4× 78 0.3× 188 0.9× 65 0.7× 203 2.4× 25 475
Patrick Beaulieu Canada 13 343 0.8× 116 0.5× 16 0.1× 101 1.1× 34 0.4× 27 594
Hans‐Georg Eckert Germany 9 536 1.2× 510 2.2× 34 0.2× 18 0.2× 40 0.5× 12 745

Countries citing papers authored by Olivier Nègre

Since Specialization
Citations

This map shows the geographic impact of Olivier Nègre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Nègre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Nègre more than expected).

Fields of papers citing papers by Olivier Nègre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Nègre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Nègre. The network helps show where Olivier Nègre may publish in the future.

Co-authorship network of co-authors of Olivier Nègre

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Nègre. A scholar is included among the top collaborators of Olivier Nègre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Nègre. Olivier Nègre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paillet, Juliette, et al.. (2025). Feeder-cell-free system for ex vivo production of natural killer cells from cord blood hematopoietic stem and progenitor cells. Frontiers in Immunology. 16. 1531736–1531736. 2 indexed citations
2.
Nègre, Olivier, et al.. (2023). Gene-addition/editing therapy in sickle cell disease. La Presse Médicale. 52(4). 104214–104214. 2 indexed citations
3.
Devillier, Raynier, Régis Peffault de Latour, Patrice Chevallier, et al.. (2023). SMART101 Donor T-Lymphoid Progenitors to Accelerate Immune Reconstitution Post-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide: SI101-02 First-in-Human Phase I/II. Blood. 142(Supplement 1). 4861–4861. 1 indexed citations
4.
Bauquet, Aurélie, et al.. (2022). T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 13. 956919–956919. 2 indexed citations
5.
Sii-Felice, Karine, et al.. (2020). Innovative Therapies for Hemoglobin Disorders. BioDrugs. 34(5). 625–647. 9 indexed citations
6.
Pattabhi, Sowmya, Swati Singh, Christopher T. Lux, et al.. (2019). In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods. Molecular Therapy — Nucleic Acids. 17. 277–288. 63 indexed citations
7.
Humbert, Olivier, Stefan Radtke, Sowmya Reddy, et al.. (2019). Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates. Science Translational Medicine. 11(503). 87 indexed citations
8.
McKenzie, Jessica, Min Luo, Sean C. Harrington, et al.. (2018). Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells. Molecular Therapy — Methods & Clinical Development. 9. 313–322. 13 indexed citations
9.
Hebert, Nicolas, Elisa Magrin, Annarita Miccio, et al.. (2018). Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy. Blood. 132(Supplement 1). 2195–2195. 3 indexed citations
10.
Lux, Christopher T., Sowmya Pattabhi, Cynthia Nourigat, et al.. (2018). TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction. Molecular Therapy — Methods & Clinical Development. 12. 175–183. 45 indexed citations
11.
Bhukhai, Kanit, Olivier Nègre, Maria Denaro, et al.. (2017). Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies. Molecular Therapy. 26(2). 480–495. 16 indexed citations
12.
Nègre, Olivier, Yves Beuzard, Jean‐Antoine Ribeil, et al.. (2016). Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β A(T87Q) - Globin Gene. Human Gene Therapy. 27(2). 148–165. 121 indexed citations
13.
Bonner, Melissa, Christopher Tipper, Holly M. Horton, et al.. (2016). 221. Staurosporine Increases Lentiviral Transduction of Human CD34+ Cells. Molecular Therapy. 24. S86–S87. 1 indexed citations
14.
Payen, Emmanuel, et al.. (2012). Lentivirus Vectors in β-Thalassemia. Methods in enzymology on CD-ROM/Methods in enzymology. 507. 109–124. 14 indexed citations
15.
Ronen, Keshet, Olivier Nègre, Nirav Malani, et al.. (2011). Distribution of Lentiviral Vector Integration Sites in Mice Following Therapeutic Gene Transfer to Treat β-thalassemia. Molecular Therapy. 19(7). 1273–1286. 55 indexed citations
16.
Nègre, Olivier, Floriane Fusil, Shoshannah L. Roth, et al.. (2011). Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion. Blood. 117(20). 5321–5331. 19 indexed citations
17.
Nègre, Olivier, Floriane Fusil, A Henri, et al.. (2008). Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Experimental Hematology. 36(4). 412–423. 1 indexed citations
18.
Maurisse, Rosalie, Bernard S. López, Arnaud Perrin, et al.. (2005). Improving gene replacement by intracellular formation of linear homologous DNA. The Journal of Gene Medicine. 7(5). 649–656. 3 indexed citations
19.
Ferret, Pierre‐Jacques, et al.. (2002). Auto-protective redox buffering systems in stimulated macrophages. BMC Immunology. 3(1). 3–3. 52 indexed citations
20.
Nègre, Olivier, et al.. (2000). Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells. Biochemical Journal. 346(3). 759–765. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A‐M Faussat Breakdown of academic impact, for papers by Kanit Bhukhai Breakdown of academic impact, for papers by Raveen Basran Breakdown of academic impact, for papers by Yuanxin Ye Breakdown of academic impact, for papers by F E Cash Breakdown of academic impact, for papers by Surinder Safaya Breakdown of academic impact, for papers by Ariadna González‐del Angel Breakdown of academic impact, for papers by A. Eigel Breakdown of academic impact, for papers by Patrick Beaulieu Breakdown of academic impact, for papers by Hans‐Georg Eckert
Rankless by CCL
2026